In this month’s newsletter, learn more about the following:
4/20 Safety Awareness Month
The CCD is excited to announce another year of 4/20 Safety Awareness Month. Throughout this month, look for emails and social media posts about being safe and responsible.
Public Consumption Prohibited
With 4/20 coming up, remember that public consumption of marijuana/marijuana products (including medical marijuana) remains prohibited. It is also prohibited under federal law on all federal lands and waters. Operating a motor vehicle under the influence of marijuana remains illegal.
Administrative Hold on Products
If appropriate, licensees will receive an automated email notification from Metrc notifying them which package tags have been placed on administrative hold. The email provides additional guidance. If a product is placed on administrative hold, contact the wholesaler before contacting the Cannabis Control Division. Current product recalls can be found on the CCD website. Link below:
External Transfers in Metrc – Seeds Only
Providers wanting to add seeds to their cultivations must obtain an “External Incoming Transfer Manifest” from METRC and open an external transfer. Certain requirements must be met to do so.
External Transfers apply to seeds only; clones cannot be entered into the External Incoming Transfer Manifest. Clones should be created under the “vegetative tab” instead of the “immature” tab.
Transfer of Location
Are you considering transferring your cannabis premise to a location where another cannabis business is currently operating? Please call CCD Business Licensing at (406) 444-0596 extension 4 for further guidance before doing so.
Metrc Transfer Hub
The Transport Hub feature in Metrc is the tool available to assist the industry with meeting the requirements outlined in ARM 42.39.413(5)(a)(b), which requires the actual date and time of departure and arrival of transported marijuana items.
For additional guidance, please see the bulletin link below:
Intravenous CBD Warning
On March 6, 2025, the FDA issued a warning about Pico IV Inc., an intravenous CBD supplement. The FDA stated:
“’Pico IV’ product is especially concerning from a public health perspective because injectable drug products can pose risks of serious harm to users. Injectable products are delivered directly into the body and therefore bypass some of the body’s key defenses against toxins and microorganisms that can lead to serious and life-threatening conditions.”
For further information click on the link below:
Additional questions?